IgNova files patent application on antibody against COVID-19
IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY).
- 23.06.2020, 18:35
- Kategoria: Nauka i technologie
- Źródło: APA-OTS